title: Transfemoral Transcatheter Aortic Valve Replacement in a Patient With Heparin-Induced Thrombocytopenia: Intraoperative Anticoagulation Management With Bivalirudin (Angiomax).
authors.affiliation: State University of New York at Stony Brook, Stony Brook University Hospital. Electronic address: scott@stonybrookmedicine.edu.
authors.forename: Bharathi
authors.initials: B
authors.lastname: Scott
authors.affiliation: New York Hospital, NY, Stony Brook, NY.
authors.forename: Christopher W
authors.initials: CW
authors.lastname: Tam
authors.affiliation: State University of New York at Stony Brook, Stony Brook University Hospital.
authors.forename: Roger S
authors.initials: RS
authors.lastname: Moon
mesh_terms: D000368:Aged; D000925:Anticoagulants / Q000008:administration & dosage*; D019468:Disease Management; D005263:Femoral Artery; D006493:Heparin / Q000009:adverse effects*; D006629:Hirudins / Q000008:administration & dosage*; D006801:Humans; D007430:Intraoperative Care / Q000379:methods*; D008297:Male; D010446:Peptide Fragments / Q000008:administration & dosage*; D011994:Recombinant Proteins / Q000008:administration & dosage; D013921:Thrombocytopenia / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy; D065467:Transcatheter Aortic Valve Replacement / Q000009:adverse effects / Q000639:trends*
chemical_list: D000925:Anticoagulants; D006629:Hirudins; D010446:Peptide Fragments; D011994:Recombinant Proteins; D006493:Heparin; C074619:bivalirudin
keywords: Angiomax; HIT; TAVR; anticoagulation; bivalirudin; cardiothoracic surgery; heparin; heparin-induced thrombocytopenia; transfemoral transcatheter aortic valve replacement